Literature DB >> 18020327

DNA cleavage by new oxovanadium(IV) complexes of N-salicylidene alpha-amino acids and phenanthroline bases in the photodynamic therapy window.

Pijus K Sasmal1, Ashis K Patra, Munirathinam Nethaji, Akhil R Chakravarty.   

Abstract

Oxovanadium(IV) complexes [VO(salmet)(B)] (1-3) and [VO(saltrp)(B)] (4-6), where salmet and saltrp are N-salicylidene-l-methionate and N-salicylidene-l-tryptophanate, respectively, and B is a N,N-donor heterocyclic base (viz. 1,10-phenanthroline (phen, 1, 4), dipyrido[3,2-d:2',3'-f]quinoxaline (dpq, 2, 5), and dipyrido[3,2-a:2',3'-c]phenazine (dppz, 3, 6)) are prepared and characterized and their DNA binding and photoinduced DNA cleavage activity studied. Complexes 1, 2, and 4 are structurally characterized by single-crystal X-ray crystallography. The molecular structure shows the presence of a vanadyl group in the VO3N3 coordination geometry. The dianionic alpha-amino acid Schiff base acts as a tridentate O,N,O-donor ligand in a meridional binding mode. The N,N-donor heterocyclic base displays a chelating mode of bonding with a N-donor site trans to the oxo group. The complexes show a d-d band in the range of 680-710 nm in DMF with a shoulder near 840 nm. They exhibit an irreversible oxidative cyclic voltammetric response near 0.8 V assignable to the V(V)/V(IV) couple and a quasi-reversible V(IV)/V(III) redox couple near -1.1 V vs SCE in DMF-0.1 M TBAP. The complexes show good binding propensity to calf thymus DNA giving binding constant values in the range from 5.2 x 10(4) to 7.2 x 10(5) M(-1). The binding site size, thermal melting, and viscosity data suggest DNA surface and/or groove binding nature of the complexes. The complexes show poor "chemical nuclease" activity in the dark in the presence of 3-mercaptopropionic acid or hydrogen peroxide. The dpq and dppz complexes show efficient DNA cleavage activity on irradiation with UV-A light of 365 nm via a mechanistic pathway involving formation of singlet oxygen as the reactive species. They also show significant DNA cleavage activity on photoexcitation in red light (>750 nm) by (1)O2 species. Observation of red-light-induced cleavage of DNA is unprecedented in the vanadium chemistry. The DNA cleavage activity is metal promoted as the ligands or vanadyl sulfate alone are cleavage inactive on photoirradiation at these wavelengths.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18020327     DOI: 10.1021/ic7011793

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  10 in total

1.  Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine.

Authors:  Nicola J Farrer; Luca Salassa; Peter J Sadler
Journal:  Dalton Trans       Date:  2009-11-11       Impact factor: 4.390

2.  Studies on Photocleavage, DNA Binding, Cytotoxicity, and Docking Studies of Ruthenium(II) Mixed Ligand Complexes.

Authors:  Yata Praveen Kumar; C Shobha Devi; A Srishailam; N Deepika; V Ravi Kumar; P Venkat Reddy; K Nagasuryaprasad; Surya S Singh; Penumaka Nagababu; S Satyanarayana
Journal:  J Fluoresc       Date:  2016-09-02       Impact factor: 2.217

3.  Synthesis, characterization, and preliminary in vitro studies of vanadium(IV) complexes with a Schiff base and thiosemicarbazones as mixed-ligands.

Authors:  Nerissa A Lewis; Fange Liu; Luke Seymour; Anthony Magnusen; Travis R Erves; Jessa Faye Arca; Floyd A Beckford; Ramaiyer Venkatraman; Antonio González-Sarrías; Frank R Fronczek; Don G Vanderveer; Navindra P Seeram; Aimin Liu; William L Jarrett; Alvin A Holder
Journal:  Eur J Inorg Chem       Date:  2012-02-01       Impact factor: 2.524

4.  Photosensitized Oxidation of Intracellular Targets: Understanding the Mechanisms to Improve the Efficiency of Photodynamic Therapy.

Authors:  Thiago Teixeira Tasso; Maurício S Baptista
Journal:  Methods Mol Biol       Date:  2022

5.  Ternary oxovanadium(IV) complexes of ONO-donor Schiff base and polypyridyl derivatives as protein tyrosine phosphatase inhibitors: synthesis, characterization, and biological activities.

Authors:  Caixia Yuan; Liping Lu; Xiaoli Gao; Yanbo Wu; Maolin Guo; Ying Li; Xueqi Fu; Miaoli Zhu
Journal:  J Biol Inorg Chem       Date:  2009-03-17       Impact factor: 3.358

6.  Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes.

Authors:  Alvin A Holder; Patrick Taylor; Anthony R Magnusen; Erick T Moffett; Kyle Meyer; Yiling Hong; Stuart E Ramsdale; Michelle Gordon; Javelyn Stubbs; Luke A Seymour; Dhiraj Acharya; Ralph T Weber; Paul F Smith; G Charles Dismukes; Ping Ji; Laura Menocal; Fengwei Bai; Jennie L Williams; Donald M Cropek; William L Jarrett
Journal:  Dalton Trans       Date:  2013-09-07       Impact factor: 4.390

7.  Oxido[N-(2-oxidobenzyl-idene-κO)leucinato-κ²N,O](1,10-phenanthroline-κ²N,N')vanadium(IV).

Authors:  Cheng-Yuan Wang; Bu-Qin Jing; Jian-Fang Dong; Lian-Zhi Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-06-13

Review 8.  Vanadium: History, chemistry, interactions with α-amino acids and potential therapeutic applications.

Authors:  Edgar Del Carpio; Lino Hernández; Carlos Ciangherotti; Valentina Villalobos Coa; Lissette Jiménez; Vito Lubes; Giuseppe Lubes
Journal:  Coord Chem Rev       Date:  2018-06-21       Impact factor: 22.315

9.  Synthesis and In Vitro Antitumor Activity of Two Mixed-Ligand Oxovanadium(IV) Complexes of Schiff Base and Phenanthroline.

Authors:  Yongli Zhang; Xiangsheng Wang; Wei Fang; Xiaoyan Cai; Fujiang Chu; Xiangwen Liao; Jiazheng Lu
Journal:  Bioinorg Chem Appl       Date:  2013-01-29       Impact factor: 7.778

10.  Improved antileishmanial activity of Dppz through complexation with antimony(III) and bismuth(III): investigation of the role of the metal.

Authors:  Edgar H Lizarazo-Jaimes; Rubens L Monte-Neto; Priscila G Reis; Nelson G Fernandes; Nivaldo L Speziali; Maria N Melo; Frédéric Frézard; Cynthia Demicheli
Journal:  Molecules       Date:  2012-10-25       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.